Roche Vorzug (ROP) reported its Q2 2026 financial results on July 23, 2026, before the market opened. The company reported earnings per share (EPS) of 10.85 CHF, beating the analyst estimate of 10.33 CHF by 5.0%. Revenue for the quarter reached 15,642 million CHF. Following the release, the stock price rose by 5.14%.
Generated automatically from our data — as of July 29, 2026
Key figures at a glance
Estimate (EPS): 10.33 CHF
Reported (EPS): 10.85 CHF
Price reaction: +5.1%
Frequently asked questions
Did Roche Vorzug beat or miss earnings-per-share expectations?
Roche Vorzug beat the analyst estimate of 10.33 CHF earnings per share (Q2 2026) by 5%, reporting 10.85 CHF.
How did Roche Vorzug stock react to the earnings report?
Roche Vorzug stock rose 5.1% on the trading day following the release.
What was Roche Vorzug's revenue in Q2 2026?
Roche Vorzug reported revenue of 15,642M CHF in Q2 2026.